Showing results (121-130 of 192) with videos related to
Sort By:
Pageof 20
Journal of Pediatric Surgery|October 8, 2016
Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocolEiso Hiyama, Tomoro Hishiki, Kenichiro Watanabe, et al.Pediatric Surgery International|October 6, 2010
Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLTTomoro Hishiki, Tadashi Matsunaga, Fumiaki Sasaki, et al.The American Journal of Pathology|May 2, 2025
Identification of a Growth-Promoting Gene Cluster in the Region 2q24 as a Driver of Tumorigenesis in Childhood HepatoblastomaMartin M Rodemann, Verena Dreschmann, Evelyn Dörner, et al.Journal of Experimental & Clinical Cancer Research : CR|November 11, 2024
Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastomaSalih Demir, Alina Hotes, Tanja Schmid, et al.International Cancer Conference Journal|October 14, 2024
First report of retroperitoneal rhabdomyosarcoma treated with space-making particle therapy for preservation of renal functionPeter J K Tokuda, Yusuke Demizu, Tianyuan Wang, et al.Journal of Experimental & Clinical Cancer Research : CR|September 19, 2025
Mechanistic models position ceritinib as a nuclear integrity disrupting therapy in pediatric liver tumorsSalih Demir, Thomas Kessler, Alina Hotes, et al.Human Pathology|July 15, 2017
Inflammatory myofibroblastic tumors of the lung carrying a chimeric A2M-ALK gene: report of 2 infantile cases and review of the differential diagnosis of infantile pulmonary lesionsMio Tanaka, Kenichi Kohashi, Kei Kushitani, et al.Cancer Science|December 15, 2018
Live single cell mass spectrometry reveals cancer-specific metabolic profiles of circulating tumor cellsYasmine Abouleila, Kaoru Onidani, Ahmed Ali, et al.Plos One|August 12, 2016
Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for NeuroblastomaShigeki Yagyu, Tomoko Iehara, Shiro Tanaka, et al.Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|December 1, 2010
Immunohistochemical detection of fibroblast growth factor receptor 3 in human breast cancer: correlation with clinicopathological/molecular parameters and prognosisKazuko Kuroso, Yasuo Imai, Masashi Kobayashi, et al.Pageof 20